Atul Deshpande, Harbour BioMed chief strategy officer & head, US operations (Harbour BioMed)
Another biotech IPO set-up? Multinational biotech leaps from round to round, scooping up cash at a blistering pace
A short four months after announcing a $75 million haul in Series B+ fundraising, the multinational biotech Harbour BioMed pulled in another round of …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
